Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The British Journal of Ophthalmology
|
January 14, 2026
Orbital inflammation in VEXAS syndrome
Clare Quigley, James Pietris, Terence Ang, et al.
Frontiers in Medicine
|
September 19, 2025
Development and implementation of the International AIDA Network Castleman's disease registry
Antonio Vitale, Jessica Sbalchiero, Valeria Caggiano, et al.
Frontiers in Immunology
|
July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry
Jurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Frontiers in Immunology
|
March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network
Valeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Frontiers in Pharmacology
|
March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry
Antonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Seminars in Arthritis and Rheumatism
|
January 31, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries
Francesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, et al.
Seminars in Arthritis and Rheumatism
|
March 30, 2024
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Antonio Vitale, Valeria Caggiano, Eduardo Martin-Nares, et al.
Frontiers in Medicine
|
January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries
Valeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Frontiers in Pharmacology
|
March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network
Antonio Vitale, Flavia Leone, Valeria Caggiano, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The British Journal of Ophthalmology
|
January 14, 2026
Orbital inflammation in VEXAS syndrome
Clare Quigley, James Pietris, Terence Ang, et al.
Frontiers in Medicine
|
September 19, 2025
Development and implementation of the International AIDA Network Castleman's disease registry
Antonio Vitale, Jessica Sbalchiero, Valeria Caggiano, et al.
Frontiers in Immunology
|
July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry
Jurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Frontiers in Immunology
|
March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network
Valeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Frontiers in Pharmacology
|
March 6, 2025
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry
Antonio Vitale, Valeria Caggiano, Flavia Leone, et al.
Seminars in Arthritis and Rheumatism
|
January 31, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries
Francesco Gavioli, Valeria Caggiano, Jessica Sbalchiero, et al.
Seminars in Arthritis and Rheumatism
|
March 30, 2024
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Antonio Vitale, Valeria Caggiano, Eduardo Martin-Nares, et al.
Frontiers in Medicine
|
January 28, 2026
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries
Valeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Frontiers in Pharmacology
|
March 24, 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network
Antonio Vitale, Flavia Leone, Valeria Caggiano, et al.
Page
of 2